Por: RTTNews Health December 01, 2023
Kazia Therapeutics Limited () has entered into a definitive agreement for the purchase and sale of up to an aggregate of 4,444,445 of the company's ADSs, each ADS representing ten ordinary shares, at a purchase price of $0.45 per ADS, in a registered direct offering. The company has also agreed to issue in a concurrent private placement unregistered warrants to purchase up to an aggregate of 4,444,445 ADSs. The warrants will have an... + full article
RTTNews USA Health December 04, 2023
Abbisko Therapeutics has entered into a licensing agreement with Merck. Under the agreement, Merck will be granted an exclusive license to commercialize products comprising or containing pimicotinib for all indications in Chinese mainland, Hong Kong, Macau and Taiwan, and... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Thursday, March 9 | Orlando Sentinel
RTTNews USA Health November 29, 2023
Kazia Therapeutics Limited () has signed a non-binding Letter of Intent with an undisclosed biotechnology company for the license of worldwide rights, other than mainland China, Hong Kong, Macao and Taiwan, to develop and commercialize pharmaceutical product containing paxalisib... + más
Unlocking Mediterranean secrets on ‘Life of Loi’ | The Boston Globe
Kazia Therapeutics Announces Registered Direct Offering | RTTNews
RTTNews USA Health November 27, 2023
Biopharmaceutical company Outlook Therapeutics, Inc. () announced Monday the receipt of the official minutes from the Type A meeting with the U.S. Food and Drug Administration (FDA) held in October 2023.The type A meeting was regarding the Complete Response Letter (CRL) dated... + más
Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease | RTTNews
Sarepta Therapeutics Updates Of BLA For Sarepta's Duchenne Muscular Dystrophy Drug Candidate | RTTNews
MarketWatch USA Business April 08, 2023
325 Capital entered into a cooperation agreement with the company on March 20 that led to the appointment of 325 Capital managing partner Michael Braner to American Public’s board on March 28. As a result, 235 Capital received a grant of 2,405 restricted shares, which are... + más
‘Chucky’ star Jennifer Tilly explains why she enjoys filming sex scenes: ‘It’s an out-of-body experience’ | Fox News
Portland receives more than 60 applicants for open city manager job | Portland Press Herald
RTTNews USA Health January 18, 2023
This commercial-stage biotechnology company developing next-generation, targeted antibody drug conjugates is aiming to achieve double-digit year-over-year revenue growth for its lead drug.The company we are profiling today is ADC Therapeutics SA () and the drug in focus is... + más
Nkarta | RTTNews
Chicago White Sox pitcher Liam Hendriks says he will undergo cancer treatment after being diagnosed with non-Hodgkin's lymphoma | CBS News
WPTV USA Nation November 30, 2022
If you or someone you love deals with a chronic disease, you're likely aware of injections. New research is indicating that in the not-too-distant future, that same medication and routine vaccinations might come in a pill form.For 10 years, biotech company has been working... + más
Op-Ed: Fentanyl pill producers used to mimic other pharmaceuticals, now they don't have to | Los Angeles Times
Hey FDA, Free the Birth Control Pill! | The Daily Beast
The Boston Globe USA Business October 12, 2022
Competition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más
Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe
See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider
About iurex | Privacy Policy | Disclaimer |